Skip to content
healthcare.dev

ZILXI

NDC 69489-212, Minocycline, aerosol, foam, from Journey Medical Corporation.

Product NDC
69489-212
Status
Listed
Labeler
Journey Medical Corporation
Dosage form
AEROSOL, FOAM
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213690
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69489-212 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MINOCYCLINE HYDROCHLORIDE15 mg/g

Pharmacologic classes

Decreased Prothrombin Activity [PE]; Tetracycline-class Drug [EPC]; Tetracyclines [CS]

Package NDCNDC-11Package
69489-212-03694890212031 CAN in 1 CARTON (69489-212-03) / 3 g in 1 CAN
69489-212-30694890212301 CAN in 1 CARTON (69489-212-30) / 30 g in 1 CAN

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cbffa96e-2446-43cf-ba5e-38c645302afd

Use it

Look up 69489-212 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69489-212 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69489-212. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.